Rajasthan Antibiotics Profile
Key Indicators
- Authorised Capital ₹ 13.88 Cr
- Paid Up Capital ₹ 9.57 Cr
- Company Age 38 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 90.84 Cr
- Satisfied Charges ₹ 729.68 Cr
- Revenue Growth 48.72%
- Profit Growth 143.00%
- Ebitda 74.63%
- Net Worth 53.75%
- Total Assets 18.67%
About Rajasthan Antibiotics
Rajasthan Antibiotics Ltd (RAL) is a leading Public Limited Indian Non-Government Company incorporated in India on 17 March 1986 and has a history of 38 years and 11 months. Its registered office is in New Delhi, India.
The Corporate was formerly known as Cepham Medical Leasing Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.88 Cr and a paid-up capital of Rs 9.57 Cr.
The company currently has active open charges totaling ₹90.84 Cr. The company has closed loans amounting to ₹729.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Rajasthan Antibiotics Ltd India are Sanjay Mittal as CFO and Ragini Khanna as Company Secretary. Aashish Pruthii, Vijaysinh Chauhan, Bindu Acharya, and Three other members serve as directors at the Company.
Company Details
- Location
New Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231DL1986PLC023616
- Company No.
023616
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Mar 1986
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Rajasthan Antibiotics Ltd offer?
Rajasthan Antibiotics Ltd offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Rajasthan Antibiotics?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aashish Pruthii  | Managing Director | 01-Jan-2007 | Current |
| Sanjay Mittal | CFO | 15-Sep-2021 | Current |
| Ragini Khanna | Company Secretary | 28-Apr-2023 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijaysinh Chauhan | Director | 19-May-2022 | Current |
| Bindu Acharya | Director | 03-Jan-2022 | Current |
| Rajesh Jha | Director | 29-Jan-2019 | Current |
| Rakesh Girdhar | Whole-Time Director | 01-Nov-2008 | Current |
| Arvind Kharabanda | Director | 19-May-2022 | Current |
Financial Performance of Rajasthan Antibiotics.
Rajasthan Antibiotics Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 48.72% increase. The company also saw a substantial improvement in profitability, with a 143% increase in profit. The company's net worth Soared by an impressive increase of 53.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rajasthan Antibiotics?
In 2022, Rajasthan Antibiotics had a promoter holding of 68.18% and a public holding of 31.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indiasign Private LimitedArvind Kharabanda is a mutual person
Hfcl LimitedArvind Kharabanda is a mutual person
- Hfcl Advance Systems Private Limited
Arvind Kharabanda is a mutual person
- Hfcl Technologies Private Limited
Arvind Kharabanda is a mutual person
- Dragonwave Hfcl India Private Limited
Arvind Kharabanda is a mutual person
Tarc LimitedBindu Acharya is a mutual person
Charges (Loans)
₹90.84 Cr
₹729.68 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 77.50 Cr
- Indian Bank : 12.40 Cr
- Hdfc Bank Limited : 0.65 Cr
- Axis Bank Limited : 0.29 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 2024 | Indian Bank | ₹3.40 Cr | Open |
| 19 Jan 2024 | Hdfc Bank Limited | ₹0.52 M | Open |
| 05 Jun 2023 | Indian Bank | ₹4.00 Cr | Open |
| 16 Feb 2023 | Hdfc Bank Limited | ₹1.50 M | Open |
| 07 Sep 2022 | Indian Bank | ₹5.00 Cr | Open |
How Many Employees Work at Rajasthan Antibiotics?
Rajasthan Antibiotics has a workforce of 314 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajasthan Antibiotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajasthan Antibiotics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
